Results 71 to 80 of about 956 (195)
In experimental studies in mice, dietary supplementation with n-3 fatty acids (FA) alleviates inflammation and increases resistance to infection. Nevertheless, TNF production capacity was found to be increased in n-3 FA-fed mice.
Buurman, Wim A. +7 more
core +1 more source
The association between dietary inflammation index and bone mineral density: results from the United States National Health and nutrition examination surveys. [PDF]
Li S, Zeng M.
europepmc +1 more source
Biphosphonates-related osteonecrosis of the jaw: multicenter study
Biphosphonates-related osteonecrosis of the jaw is defined as an exposure of necrotic bone in maxillofacial region,which persists more than 8 weeks in patients treated or,in course of treatment whit biphosphonate, not been subjected to radiation therapy ...
GARAU, VALENTINO +8 more
core
Dentists' Awareness of Medication-Related Osteonecrosis of the Jaw (Risk Factors, Drugs, and Prevention) in the Republic of Croatia. [PDF]
Bival S +5 more
europepmc +1 more source
Ying-Chen Chen,1,* Hsiu-O Ho,1,* Chiao-Chi Chiu,1 Ming-Thau Sheu1,2 1School of Pharmacy, College of Pharmacy, Taipei Medical University, 2Clinical Research Center and Traditional Herbal Medicine Research Center, Taipei Medical University Hospital, Taipei,
Chen YC, Ho HO, Chiu CC, Sheu MT
doaj
The molecular triad, which includes the receptor activator of nuclear factor kappa-B ligand (RANKL), its receptor RANK, and the endogenous soluble RANKL decoy receptor osteoprotegerin (OPG), has emerged as an important determinant of bone metabolism.
Mountzios, Giannis +15 more
core
Biphosphonate-Related Osteonecrosis (BRONJ) in Cancer Patients: Retrospective Study
GİRİŞ ve AMAÇ: Bisfosfonatlar genellikle menapoz sonrası, kortikosteroidin artırdığı osteoporoz, Paget hastalığı, malinite ve osteolizis ile ilişkili hiperkalsemi ve metastatik kemik hastalıkları tedavisinde kullanılır. Bifosfonata bağlı osteonekroz çene
Candan Efeoğlu +3 more
core +2 more sources
Diffuse skeletal pain after administration of alendronate
Background : Osteoporosis is caused by bone resorption in excess of bone formation, and bisphosphonates, are used to inhibit bone resorption.
Ozaras, Nihal, Rezvani, Aylin
core +2 more sources
We present the first case of concomitant hip and jaw osteonecrosis in a 10-year-old child with aplastic anemia undergoing a transplant. Biphosphonate treatment may be beneficial for hip osteonecrosis but harmful for jaw osteonecrosis.
TOPUZ TÜRKCAN, BÜŞRA +5 more
core +1 more source
Mice are protected from lytic bone lesions using bisphosphonates and osteoprotegerin (m OPG).
A) Representative CT Scan images of skulls of MuTuDC injected mice (subcutaneously on the calvaria, close to the left parietal bone). Mice were treated with either PBS (control) or the biphosphonate Aclasta B) Representative stereomicroscopic images of ...
Paolo Vezzoni (70525) +11 more
core +1 more source

